Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 48 citing articles:

Recent advances in hepatocellular carcinoma therapy
Rinku Dutta, Ram I. Mahato
Pharmacology & Therapeutics (2017) Vol. 173, pp. 106-117
Open Access | Times Cited: 249
Lipid-based nanoparticle technologies for liver targeting
Roland Böttger, Griffin Pauli, Po-Han Chao, et al.
Advanced Drug Delivery Reviews (2020) Vol. 154-155, pp. 79-101
Closed Access | Times Cited: 180
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine
Zahra Izadiyan, Misni Misran, Katayoon Kalantari, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 1213-1262
Open Access | Times Cited: 2
Tumors and Their Microenvironment Dual‐Targeting Chemotherapy with Local Immune Adjuvant Therapy for Effective Antitumor Immunity against Breast Cancer
Caifeng Deng, Quan Zhang, Mengdi Jia, et al.
Advanced Science (2019) Vol. 6, Iss. 6
Open Access | Times Cited: 142
Cancer nanotheranostics: A review of the role of conjugated ligands for overexpressed receptors
Lydia Ramzy, Maha Nasr, Abdelkader A. Metwally, et al.
European Journal of Pharmaceutical Sciences (2017) Vol. 104, pp. 273-292
Closed Access | Times Cited: 92
Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances
Khaled Y. Mahmoud, Shady A. Swidan, Mohamed A. El-Nabarawi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 66
Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma
Benjian Gao, Jia Luo, Ying Liu, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 4073-4085
Open Access | Times Cited: 57
Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer
Yitong Li, Ruihang Zhang, Zhen Xu, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 909-925
Open Access | Times Cited: 40
Review targeted drug delivery systems for norcantharidin in cancer therapy
Bingtao Zhai, Jing Sun, Yajun Shi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 39
Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases
Zhe Ma, Bing Zhang, Yuqi Fan, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 117, pp. 109128-109128
Open Access | Times Cited: 69
Nanocarrier-mediated antioxidant delivery for liver diseases
Senlin Li, Huiru Li, Xiaoding Xu, et al.
Theranostics (2020) Vol. 10, Iss. 3, pp. 1262-1280
Open Access | Times Cited: 61
Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment
Anita K. Bakrania, Gang Zheng, Mamatha Bhat
Pharmaceutics (2021) Vol. 14, Iss. 1, pp. 41-41
Open Access | Times Cited: 45
Recent strategies on targeted delivery of thrombolytics
Ting Huang, Ni Li, Jianqing Gao
Asian Journal of Pharmaceutical Sciences (2019) Vol. 14, Iss. 3, pp. 233-247
Open Access | Times Cited: 53
The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target
Lorena Baboçi, Sara Capolla, Federica Di Cintio, et al.
Journal of Oncology (2020) Vol. 2020, pp. 1-15
Open Access | Times Cited: 50
Functionalized liposomes as drug nanocarriers for active targeted cancer therapy: a systematic review
Hanieh Abbasi, Nadereh Rahbar, Maryam Kouchak, et al.
Journal of Liposome Research (2021) Vol. 32, Iss. 2, pp. 195-210
Open Access | Times Cited: 33
One-Step Microfluidic Fabrication of Multi-Responsive Liposomes for Targeted Delivery of Doxorubicin Synergism with Photothermal Effect
Songwei Lv, Ran Jing, Xiaowu Liu, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 7759-7772
Open Access | Times Cited: 31
Chitosan-modified mesoporous silica nanoparticles for the oral delivery of Norcantharidin: In vitro and in vivo assessment
Daixia Huo, Qiuxu An, Mingzhe Li, et al.
Microporous and Mesoporous Materials (2024) Vol. 369, pp. 113013-113013
Closed Access | Times Cited: 4
Multifunctional and stimuli-responsive liposomes in hepatocellular carcinoma diagnosis and therapy
Seyedeh Setareh Samaei, Mahshid Daryab, Sarah Gholami, et al.
Translational Oncology (2024) Vol. 45, pp. 101975-101975
Open Access | Times Cited: 4
Novel folated pluronic F127 modified liposomes for delivery of curcumin: preparation, release, and cytotoxicity
Ziling Li, Xiangyuan Xiong, Shengfeng Peng, et al.
Journal of Microencapsulation (2020) Vol. 37, Iss. 3, pp. 220-229
Closed Access | Times Cited: 28
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma
Cristian Turato, Anna Balasso, Vinicio Carloni, et al.
Journal of Controlled Release (2017) Vol. 268, pp. 184-197
Closed Access | Times Cited: 31
Oxyresveratrol prevents murine H22 hepatocellular carcinoma growth and lymph node metastasis via inhibiting tumor angiogenesis and lymphangiogenesis
Yuanqi Liu, Wei Ren, Yang Bai, et al.
Journal of Natural Medicines (2018) Vol. 72, Iss. 2, pp. 481-492
Closed Access | Times Cited: 30
Synergistic co-delivery of diacid metabolite of norcantharidin and ABT-737 based on folate-modified lipid bilayer-coated mesoporous silica nanoparticle against hepatic carcinoma
Minchen Liu, Jue Tu, Yi Feng, et al.
Journal of Nanobiotechnology (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 22
Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness
Rossella Farra, Francesco Musiani, Francesca Perrone, et al.
Molecules (2018) Vol. 23, Iss. 4, pp. 777-777
Open Access | Times Cited: 21
Preparation and in vitro and in vivo evaluations of 10-hydroxycamptothecin liposomes modified with stearyl glycyrrhetinate
Ting Zhou, Xin Tang, Wei Zhang, et al.
Drug Delivery (2019) Vol. 26, Iss. 1, pp. 673-679
Open Access | Times Cited: 21
Cantharidic acid induces apoptosis through the p38 MAPK signaling pathway in human hepatocellular carcinoma
I‐Che Feng, Ming‐Ju Hsieh, Pei‐Ni Chen, et al.
Environmental Toxicology (2017) Vol. 33, Iss. 3, pp. 261-268
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top